Follow
Beatriz Peláez Lorenzo
Beatriz Peláez Lorenzo
Médico adjunto. Hospital Clínico Universitario Valladolid
Verified email at saludcastillayleon.es
Title
Cited by
Cited by
Year
Efficacy of neoadjuvant carboplatin plus docetaxel in triple-negative breast cancer: combined analysis of two cohorts
P Sharma, S López-Tarruella, JA García-Saenz, C Ward, CS Connor, ...
Clinical cancer research 23 (3), 649-657, 2017
1392017
Pathological response and survival in triple-negative breast cancer following neoadjuvant carboplatin plus docetaxel
P Sharma, S López-Tarruella, JA García-Saenz, QJ Khan, HL Gómez, ...
Clinical Cancer Research 24 (23), 5820-5829, 2018
1092018
Predictors for survival with cabazitaxel (CBZ) in metastatic, castration-resistant prostate cancer (mCRPC): Long term follow-up of the Spanish registry.
I González-Maeso, N Lainez, D Castellano, I Garcia Carbonero, ...
Journal of Clinical Oncology 35 (6_suppl), e602-e602, 2017
2017
Mesenteric extragastrointestinal stromal tumor (EGIST): a rare variant with unusual behaviour
B Peláez-Lorenzo, CA Rodríguez Arias, LA Mata Juberías
Revista Colombiana de Cancerología 20 (2), 87-91, 2016
2016
Tumor del estroma extragastrointestinal (EGIST) mesentérico: entidad rara con evolución atípica
B Peláez-Lorenzo, CAR Arias, LAM Juberías
Revista Colombiana de Cancerología 20 (2), 87-91, 2016
2016
Consistent benefit survival with cabazitaxel (CBZ) in metastatic castration resistant prostate cancer (mCRPC) in Spain: Updated results.
I Gonzalez, DE Castellano, E Esteban, Q Perez Arnillas, J Munarriz, ...
Journal of Clinical Oncology 32 (15_suppl), e16088-e16088, 2014
2014
Control evolutivo del paciente infectado por el VIH. Cofactores de progresión
XCO de Barrón, DA Legarda, BP Lorenzo
The system can't perform the operation now. Try again later.
Articles 1–7